In Arizona, joining the ranks of Akron Biotechnology and others we’ve covered in the past, Lattice Biologics Ltd. is joining nearly 100 organizations in the Advanced Regenerative Manufacturing Institute (ARMI) an initiative comprised of public sector, government, nonprofits, and private sector aimed to advance next-generation technologies and biofabrication for cells, tissue and organs. Lattice Biologics is using human tissue based scaffolds that can support ingrowth of stem cells, preserve phenotypes of engrafted cells, and improve the time it takes for patients to heal. They use extracellular matrix from stem cells or from muscle or placenta tissue to create their biomaterial for cellular therapies and tissue engineering. Lattice Biologics is working with Arizona-based ASU Biodesign on their products.
Latest article
Fishway hooks Multus to jointly accelerate cultivated fish
In the United Kingdom, Fishway and Multus Biotechnology have partnered to bring cultivated fish to market faster.
The pact will leverage Fishway's expertise in...
Pirelli unveils biobased tires for Range Rovers
In Milan, tire manufacturer Pirelli has launched the first standard production tire for the global market made with over 70% biobased and recycled materials,...
MIT students design 3D printer that converts home food waste into knick-knacks
In Boston, Massachusetts Institute of Technology students Biru Cao and Qiqing Wang have developed an AI-drive desktop 3D printer that converts household food waste...